Pramlintide
Drug Details
- Generic Name
- Pramlintide
- Brand Names
- N/A
- Application Number
- Sponsor
- Qingdao Biopeptek Co., Ltd.
- NDC Codes
- 2
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- PRAMLINTIDE, PRAMLINTIDE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE SYMLIN is indicated as an adjunctive treatment in patients with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. SYMLIN is an amylin analog indicated for patients with type 1 or type 2 diabetes who use mealtime insulin and have failed to achieve desired glycemic control despite optimal insulin therapy (1) .